RxSight (RXST) Receivables - Net (2020 - 2025)
RxSight's Receivables - Net history spans 6 years, with the latest figure at $23.4 million for Q4 2025.
- For Q4 2025, Receivables - Net fell 22.19% year-over-year to $23.4 million; the TTM value through Dec 2025 reached $23.4 million, down 22.19%, while the annual FY2025 figure was $23.4 million, 22.19% down from the prior year.
- Receivables - Net reached $23.4 million in Q4 2025 per RXST's latest filing, down from $24.2 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $31.0 million in Q1 2025 to a low of $3.9 million in Q2 2021.
- Average Receivables - Net over 5 years is $16.7 million, with a median of $15.2 million recorded in 2023.
- Peak YoY movement for Receivables - Net: skyrocketed 125.34% in 2022, then fell 22.19% in 2025.
- A 5-year view of Receivables - Net shows it stood at $4.9 million in 2021, then surged by 125.34% to $11.0 million in 2022, then skyrocketed by 85.11% to $20.3 million in 2023, then skyrocketed by 48.17% to $30.0 million in 2024, then fell by 22.19% to $23.4 million in 2025.
- Per Business Quant, the three most recent readings for RXST's Receivables - Net are $23.4 million (Q4 2025), $24.2 million (Q3 2025), and $28.1 million (Q2 2025).